4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001493152-26-049370
CHAIRMAN AND CEO bought 1,356,990 shares at an average $0.02 ($23,537)
From the SEC's structured data for this filing
Trades in this filing
Trieu Vuong · CHAIRMAN AND CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-29 | Purchase : show line 1 in the form | +1,044,990 | $0.02 | $17,765 | 95,481,309 | D |
| 2026-10-28 | Purchase : show line 2 in the form | +312,000 | $0.02 | $5,772 | 94,436,319 | D |
| Open-market purchases · 1,356,990 sh · avg $0.02 · $23,537 | ||||||
Loading xslF345X06/ownership.xml…